Peptide Compass · Research
Semaglutide: research, prices and suppliers
A GLP-1 receptor agonist, known as an approved medication and listed here as a research substance for metabolic regulation.
Semaglutide is a GLP-1 receptor agonist approved as a medication under several brand names. It is the subject of extensive clinical research on metabolic and satiety regulation. The research batches listed here are not equivalent to approved medications and are intended for laboratory use only.
Facts
- CAS number: 910463-68-2
- Molecular weight: 4114 g/mol
- Amino acids: 31
- Half-life: ≈ 1 week (elimination, Ozempic prescribing information)
- Purity specification: ≥ 99 % (HPLC, commercial standard)
Evidence
- In a randomized trial with 1,961 adults with overweight or obesity, weekly semaglutide over 68 weeks led to a mean body weight loss of 14.9 percent versus 2.4 percent under placebo. Wilding JPH et al. 2021, New England Journal of Medicine, PMID 33567185
- In a cardiovascular outcomes trial with 3,297 people with type 2 diabetes and elevated cardiovascular risk, semaglutide was associated with a 26 percent lower rate of major cardiovascular events compared to placebo. Marso SP et al. 2016, New England Journal of Medicine 375:1834-1844, PMID 27633186
Frequently asked questions
Is semaglutide an approved medication?
Yes, semaglutide is approved as a prescription medication under the names Ozempic, Wegovy, and Rybelsus. The substance described here is a research batch only, not a finished pharmaceutical product.
How does semaglutide differ from retatrutide?
Semaglutide acts only on the GLP-1 receptor, while retatrutide additionally acts on the GIP and glucagon receptors. Retatrutide is an investigational molecule and not yet approved, while semaglutide is already approved.
What is semaglutide used for as a medication?
As an approved medication, semaglutide is prescribed for type 2 diabetes and weight management. This page describes the substance exclusively as a research chemical for laboratory purposes.
Documented prices
Prices are recorded snapshots. Each entry states its date, currency and pack variant. Shipping, tax treatment, discount conditions and availability must be rechecked in the shop. A low price is not evidence of quality.
List prices excluding shipping and discounts. Currency and product variants must be compared separately. Availability and delivered batch have not been verified.
| Vendor | Pack | List price | Price/mg | Recorded | Source |
|---|---|---|---|---|---|
| Driada | 2 mg | 39 EUR | 19.5 EUR/mg | 2026-09-15 | Product page · Ad |
| Europa-Peptide | 5 mg | 37.9 EUR | 7.58 EUR/mg | 2026-09-15 | Product page · Ad |
| Smart Peptides | 10 mg | 49.9 EUR | 4.99 EUR/mg | 2026-09-15 | Product page · Ad |
| Peptide Shop Deutschland | 10 mg | 79.99 EUR | 8.0 EUR/mg | not established | Product page · Ad |
| American Peptides | 5 mg | 60 USD | 12.0 USD/mg | 2026-09-15 | Product page · Ad |
Questions about interpretation
What does the search “Semaglutide protocol” mean?
“Protocol” is often used to mean a regimen. This page explains research and documented listings. It contains no doses, cycles or instructions for human use. An online regimen is not scientifically validated simply because it is widely shared.
Sources and data basis
These references come from the existing dataset. A link alone verifies neither a study claim nor supplier quality. Uncertainty remains explicit where records are undated or incomplete.
Where to go next
Created with AI assistance. This new edition has not yet received independent editorial review.